搜尋結果
Takeda's seizure drug fails to meet main goal in late-stage studies
Reuters· 6 日前Japan's Takeda said on Monday its experimental drug to treat epileptic disorders failed to ...
啓明創投|看好AI醫療應用 深耕生物及硬科技 屢獲佳績
信報· 6 日前福布斯全球最佳創投人榜(The Midas List)月初出爐,連續6次上榜、今年位列第40名的啓明創投主管合夥 ...
減肥筆市場未來十年達1000億美元 諾和諾德、禮來兩家瓜分
鉅亨網 via Yahoo財經香港· 2 日前諸如諾和諾德 (NVO-US) 出品的 Wegovy 和禮來公司 (LLY-US) 生產的 Zepbound 這類減肥藥開拓了一個市 ...
Before US Senate panel, scientist defends rejection of Covid-19 lab leak theory
South China Morning Post· 4 日前“Despite these private doubts, publicly these so-called experts and their allies were ...
NK 細胞是比 CAR-T 更好的癌症療法?
科技新報 TechNews· 2 日前CAR-T(嵌合抗原受體 T 細胞)療法是免疫療法,2017 年首獲美國 FDA 批准治療血癌,是當時重大突破。此法利用病患自己的免疫細胞,改造放大數量後能攻擊癌細胞 ...
Weight loss drug contender Zealand Pharma jumps 18% on trial results
CNBC· 2 日前Shares of Denmark's Zealand Pharma popped on Friday, notching a record high after an ...
美股前瞻 | 三大股指期貨齊漲,今晚三巫日“駕到”
阿思達克財經網· 2 日前1. 6月21日(週五)美股盤前,美股三大股指期貨齊漲。截至發稿,道指期貨漲0.02%,標普500指數期貨漲0.0...
BioNTech Cancer Drug Licensed From MediLink Faces FDA Delay
Bloomberg· 6 日前The Food and Drug Administration delayed a breast- and lung-cancer trial of an experimental ...
Zealand Pharma Shares Jump 17% After Positive Trial Results For Ozempic Competitor
Forbes· 2 日前Shares for Zealand Pharma rose by over 17% on Friday, after the Danish biotech firm announced positive trial results for ...
25 Companies Hiring Now For Fully Remote Jobs In 2024
Forbes· 2 日前Within the United States, the professional, scientific, and computer-related occupations have the highest shares of job ...